Form SC14D9C Forte Biosciences, Inc. Filed by: Forte Biosciences, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
Forte Biosciences, Inc.
(Name of Subject Company)
Forte Biosciences, Inc.
(Name of Person Filing Statement)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
34962G208
(CUSIP Number of Class of Securities)
Paul A. Wagner, Ph.D.... (continue reading...)
Form 10-Q Clean Energy Technologie For: Mar 31
false
Q1
--12-31
0001329606
... (continue reading...)
Form 4 Greenwich LifeSciences, For: Jul 23 Filed by: Patel Snehal
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form D SUMITOMO MITSUI FINANCIA
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form S-4/A ONE Nuclear Energy LLC Filed by: Hennessy Capital Investment Corp. VII
http://archive.fast-edgar.com/20260727/A92ZV22CZW2R7TSD222G2ZY2LPF9ZZ22ZV82
Filed on: July 27, 2026
More SEC Filings
View Older Stories-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 6-K Sanofi For: Jul 27
-
Form S-4/A NON INVASIVE MONITORING
-
Form 8-K Profusa, Inc. For: Jul 27
-
Form 6-K The9 LTD For: Jul 27
-
Form 8-K ENSIGN GROUP, INC For: Jul 27
-
Form 8-K Baker Hughes Co For: Jul 26
-
Form 4 36Kr Holdings Inc. For: Jul 01 Filed by: Feng Dagang
-
Form 6-K ICICI BANK LTD For: Jul 24
-
Form 6-K ERICSSON LM TELEPHONE For: Jul 27
-
Form 13F-HR Shengqi Capital (Hong For: Jun 30
-
Form 6-K Radiopharm Theranostics For: Jul 27
-
Form 8-K Forte Biosciences, Inc. For: Jul 26
-
Form 424B5 NANOVIRICIDES, INC.
-
Form 6-K Li Auto Inc. For: Jul 27
-
Form DEFA14A FLEX LTD.
-
Form 6-K Lufax Holding Ltd For: Jul 27
-
Form 424B5 Radiopharm Theranostics
-
Form 10-Q ENSIGN GROUP, INC For: Jun 30
-
Form 6-K HDFC BANK LTD For: Jul 24
-
Form 8-K Antero Midstream Corp For: Jul 24
-
Form 6-K ARGENX SE For: Jul 27
-
Form 424B3 REPUBLIC OF CHILE
-
Form EFFECT Bone Biologics Corp
-
Form DEFA14A SOUTHERN CALIFORNIA GAS
-
Form 8-K Artificial Intelligence For: Jul 27
-
Form 6-K Zhihu Inc. For: Jul 27
-
Form 8-K International Media Acqu For: Jul 24
-
Form 6-K Trip.com Group Ltd For: Jul 27
-
Form 8-K SemiLEDs Corp For: Jul 27
-
Form 6-K Veraxa Biotech Holding For: Jul 27
-
Form EFFECT Artificial Intelligence
-
Form 6-K Legend Biotech Corp For: Jul 27
-
Form EFFECT Brenmiller Energy Ltd.
-
Form EFFECT Jaguar Health, Inc.
-
Form EFFECT HNO International, Inc.
-
Form EFFECT Jaguar Health, Inc.
-
Form EFFECT Leef Brands Inc.
-
Form EFFECT United Maritime Corp
-
Form EFFECT ACCENDRA HEALTH INC/VA/
-
Form EFFECT QUANTUM CORP /DE/
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Cyclerion Therapeutics,
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Vicarious Surgical Inc.
-
Form EFFECT Alpha Summit Strategic
